David Harburger is a registered patent attorney working closely with clients from the early stages of formation and beyond to align their intellectual property (IP) strategy with their business goals. He advises biotech clients on patent preparation and prosecution, patent portfolio management, freedom-to-operate, patent invalidity, non-infringement, IP and clinical strategy coordination, and IP due diligence matters. Having spent more than a decade conducting academic biomedical research, David has extensive familiarity with patent law issues specific to life sciences-based technologies, including biochemistry, bioenergy systems, cell signaling, diagnostics, genetics, immunology, microbiome, synthetic biology, and large and small molecule therapeutics. He has architected IP strategies for groundbreaking emerging technology companies in the synthetic biology and immunotherapy fields to align with their entry into the public market. He also advises venture capital and private equity investors in IP-related matters in financing rounds.
- U.S. and international patent strategy
- Patent portfolio management
- Life sciences
- Patent prosecution and opinions
- IP due diligence